SherpaBonds
US78081BAJ26 · Corp · USDInvestment Grade · Baa2

Royalty Pharma Plc 1.75% 2027/09

Royalty Pharma PlcUnited StatesGLOBALSenior Unsecured
SHARE
▶ Start radio
MID PRICE
96.90
par = 100
YIELD TO MAT.
4.44%
semi-annual
COUPON
1.750%
semi-annual · fixed
MATURITY
2027-09-02
bullet · 1.31y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Sign inSign up free

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
1.27 y
1bp ↑ ≈ -0.013% P&L
Convexity
2.25
higher = more curvature
Years to maturity
1.31 y
YTM source
Ingested
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
Vanguard Short-Term Corporate Bond
Vanguard
US Corporate Short$35.2M—0.07%2026-03-31
Vanguard Total Bond Market
Vanguard
US Aggregate$16.8M—0.00%2026-03-31
Invesco BulletShares 2027 Corporate Bond
Invesco
BulletShares 2027 Corporate$9.8M▲ $2K0.21%2026-05-05
Vanguard Short-Term Bond
Vanguard
US Aggregate Short$8.7M—0.01%2026-03-31
iShares iBonds Dec 2027 Term Corporate
iShares
iBonds 2027 Corporate$6.9M▼ $4K0.18%2026-05-07
iShares 1-5 Year Investment Grade Corporate Bond
iShares
US IG Corporate 1-5Y$5.2M▼ $2K0.02%2026-05-07
iShares Core U.S. Aggregate Bond
iShares
US Aggregate$4.8M▼ $3K0.00%2026-05-07
SPDR Portfolio Short Term Corporate Bond
SPDR
US IG Corporate Short$3.7M▲ $1K0.04%2026-05-05
SPDR Portfolio Intermediate Term Corporate Bond
SPDR
US IG Corporate Intermediate$2.2M▲ $7370.02%2026-05-05
iShares Broad USD Investment Grade Corporate Bond
iShares
US Broad IG Corporate$1.8M▼ $7470.01%2026-05-07
iShares Core Universal USD Bond
iShares
US Aggregate$1.0M▼ $5420.00%2026-05-07
iShares 0-5 Year Investment Grade Corporate Bond
iShares
US IG Corporate$765K▼ $4970.03%2026-05-07
SPDR Portfolio Aggregate Bond
SPDR
US Aggregate$439K▲ $1460.00%2026-05-05
iShares Core 1-5 Year USD Bond
iShares
US Short-Term Core$254K▼ $1370.01%2026-05-07
iShares Intermediate Government/Credit Bond
iShares
US Govt/Credit$237K▼ $1280.01%2026-05-07
iShares ESG Advanced Universal USD Bond
iShares
US Aggregate$58K▼ $310.01%2026-05-07
iShares iBonds 1-5 Year Corporate Ladder
iShares
iBonds Corporate$28K—0.04%2026-05-06
iShares BBB Rated Corporate Bond
iShares
US IG Corporate$27K▼ $180.05%2026-05-07
iShares Interest Rate Hedged U.S. Aggregate Bond
iShares
US Aggregate$174—0.00%2026-05-07
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-07

Institutional footprint · signal-level holdings

46/ 100Active coverage
Interpretation. Light institutional footprint, with net distribution
HOLDERS
19
▲ 2 signals in 7d
AGGREGATE EXPOSURE
$97.9M
USD across all
TOP CONCENTRATION
35.9%
largest holder
FLOW
▼ $14.0M
▲ 2 signals in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
96,901 USD
PRICE
96.90

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
RPRX 1 3/4 09/02/27
FIGI
BBG011Q4QQ21
CUSIP
78081BAJ2
ISIN
US78081BAJ26
Type
Corp
Issued
2021-03-02
Face value
100 USD
Ticker
RPRX 1.75 09/02/27
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

RPRX · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.

Bonds like this

HEURISTIC

Same currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.

Royalty Pharma Plc 5.15% 09/2029
Royalty Pharma Plc
2029-09
4.60%
+16 bps yield+2y duration9 signals in commonSame issuer
Royalty Pharma Plc 2.2% 09/2030
Royalty Pharma Plc
2030-09
4.68%
+24 bps yield+3y duration9 signals in commonSame issuer
Royalty Pharma Plc 4.45% 03/2031
Royalty Pharma Plc
2031-03
4.71%
+27 bps yield+4y duration7 signals in commonSame issuer
Royalty Pharma Plc 2.15% 09/2031
Royalty Pharma Plc
2031-09
4.78%
+34 bps yield+4y duration7 signals in commonSame issuer
Royalty Pharma Plc 5.2% 09/2035
Royalty Pharma Plc
2035-09
5.28%
+84 bps yield+8y duration6 signals in commonSame issuer
Royalty Pharma Plc 5.9% 09/2054
Royalty Pharma Plc
2054-09
6.03%
+159 bps yield+27y duration6 signals in commonSame issuer